Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary hemorrhagic telangiectasia (HHT), the world's second-most-common inherited bleeding disorder, affects approximately 1-in-5,000 people and can have life-threatening complications, but there are currently no U.S. FDA-approved drugs to treat HHT. Rising 'catchable' cancers: Oncologists in US warn of HPV-linked surge US oncologists are alarmed by the rising cancer cases linked to sexually transmitted diseases like HPV. Although vaccines have proven effective in reducing cervical cancer, their adoption in the US is poor. Increasing public awareness and vaccination efforts could significantly reduce these preventable cancers. How did pirates really talk? September 19 is Talk Like a Pirate Day. But where does "pirate speak" come from, and is this how historical pirates really talked? |
Asphalt Schoolyards Get a Shady Makeover Schools across the country are adding trees, tent-like structures and water to their playgrounds as temperatures soar. Harvey Weinstein pleads not guilty to new sex crime charge in New York Harvey Weinstein, while awaiting retrial in his #MeToo case, has pleaded not guilty to a new sex crime charge that accuses him of "forcing oral sex on a woman" in 2006. What you need to know about Earth's new, temporary mini-moon Dubbed the 2024 PT5, the 'mini-moon' will orbit Earth for nearly two months. It comes in a season of lunar phenomena. Rocket Lab to launch 2nd mission for Internet of Things company, Kinéis The mission will be the 53rd launch of an Electron rocket to date. Liftoff is set for Sept. 19 at 11 a.m. NZST (Sept. 18 at 7 p.m. EDT, 2300 UTC). |
Píše se o |